A Study of ORX142 in Healthy Adult Subjects, Including Subjects 18 to 80 Years of Age
Recruiting
Phase 1
Interventional Study
Excessive Daytime Sleepiness
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 208 (estimated)
- Sponsor
- Centessa Pharmaceuticals (UK) Limited · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Key Inclusion Criteria:
1. Healthy males or females as determined by assessments at the Screening Visit.
For Parts A, B, C, and E:
a. Participants must be at least 18 years of age and no more than 55 years of age at the Screening
2. For Part D:
a .Participants must be at least 60 years of …
Contacts